An open-label, randomized, comparative 3-way cross-over study to evaluate the effect of food on the 24-hour intragastric pH at day 5 after twice daily oral administration of PN 200 (omeprazole/naproxen) in healthy volunteers.
Phase of Trial: Phase I
Latest Information Update: 02 Feb 2010
At a glance
- Drugs Omeprazole/naproxen (Primary)
- Indications Arthritis; Musculoskeletal pain; NSAID-induced gastrointestinal damage
- Focus Pharmacodynamics
- Sponsors POZEN
- 20 Oct 2009 Actual initiation date changed from Jan 2007 to Feb 2008 as reported by ClinicalTrials.gov.
- 03 Apr 2007 New trial record.